Buffett plows money into GSK, Sanofi

Where Warren Buffett goes, others follow--and that's why anyone holding GlaxoSmithKline or Sanofi-Aventis options is smiling today. The billionaire investor's holding company told the Securities and Exchange Commission that it now owns 1.5 million of GSK's American Depository Receipts, valued at $76.1 million, and 3.6 million Sanofi ADRs, worth $162.5 million. GSK is already up 1.5 percent on the news.

- read the report from Forbes
- see more at Interactive Investor

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.